Lombard Medical Technologies (LMT)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | n/a |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 13.0 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Dec | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | |||||||||
| Operating Profit | £m | |||||||||
| Net Profit | £m | |||||||||
| EPS Reported | p | |||||||||
| EPS Normalised | p | |||||||||
| EPS Growth | % | |||||||||
| PE Ratio | x | |||||||||
| PEG | x | |||||||||
| Profitability | ||||||||||
| Operating Margin | % | |||||||||
| ROA | % | |||||||||
| ROCE | % | |||||||||
| ROE | % | |||||||||
| Cashflow | ||||||||||
| Op. Cashflow ps | p | |||||||||
| Capex ps | p | |||||||||
| Free Cashflow ps | p | |||||||||
| Dividends | ||||||||||
| Dividend ps | p | |||||||||
| Dividend Growth | % | |||||||||
| Dividend Yield | % | |||||||||
| Dividend Cover | x | |||||||||
| Balance Sheet | ||||||||||
| Cash etc | £m | |||||||||
| Working Capital | £m | |||||||||
| Net Fixed Assets | £m | |||||||||
| Net Debt | £m | |||||||||
| Book Value | £m | |||||||||
| Average Shares | m | |||||||||
| Book Value ps | p | -58.3% | ||||||||
FINANCIAL BRIEF: For the fiscal year ended 31 December 2012, Lombard Medical Technologies PLC revenues decreased 3% to L3.9M. Net loss decreased 18% to L8.3M. Revenues reflect Rest of the World segment decrease of 21% to L446K, United States of America segment decrease of 71% to L44K. Lower net loss reflects Research and development expenses decrease of 30% to L4.6M (expense), Administrative Expenses decrease of 28% to L2.3M (expense). more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Dec '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 0 | 0 | 1 |
Lombard Medical Technologies PLC (LMT) is a medical technology company. The Company’s principal activities are the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through its own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. LMT’s Aorfix product is the endovascular stent graft for patients with tortuous vascular anatomy. Aorfix combines a design and technology that result in clinical performance in endovascular aortic repair (EVAR) patients with complex anatomy. The product is used to treat complex aneurysms up to 90 degrees. Aorfix includes nitinol rings and a helical scaffold covered by a woven polyester fabric. LMT’s subsidiaries include Lombard Medical Limited, PolyBioMed Limited, LionMedical Limited, Lombard Medical Technologies Inc Lombard Medical Scotland Limited.
Directors: John Rush (CEO) 44, Simon Hubbert (CFO) 44, Simon Neathercoat (CTO) 53,
No. of Employees: 97 No. of Shareholders: n/a
| Last Annual | December 31st, 2012 |
| Last Interim | December 31st, 2012 |
| Shares in Issue | 32,344,669 |
| Free Float | 17.8m (88.3%) |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | Lombard Medical House,4 Trident Park Basil Hill Road, DIDCOT, OX11 7HJ, United Kingdom |
| Web | http://www.lombardmedical.com/ |
| Phone | +44 1235 750800 |
| Contact | Rhod Jones (Secy.) |
| Registrar | Capita Registrars Limited (Huddersfield) |
| Auditors | PricewaterhouseCoopers LLP |
| Fri 11:38am | Results of General Meeting and Total Voting Rights |
| Fri 7:00am | Share Option Grant |
| Thu 7:00am | Result of Offer |
| 24th May | Proposed Placing and Subscription of Shares |
| 23rd May | Result of AGM |
| 7th May | Files Petition for Inter Partes Review of Patent |
Recent ↓
